Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone.
about
Opioid agonist treatment for pharmaceutical opioid dependent peopleDiscontinuation of buprenorphine maintenance therapy: perspectives and outcomesProbuphine® (buprenorphine implant): a promising candidate in opioid dependence.Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies.Buprenorphine implants in medical treatment of opioid addiction.Buprenorphine for managing opioid withdrawal.Update on pharmacotherapy for treatment of opioid use disorder.Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential.Sex Differences in Regional Brain Glucose Metabolism Following Opioid Withdrawal and Replacement.Advances in the delivery of buprenorphine for opioid dependence.Treatment of opioid dependence with buprenorphine: current update.Striatal dopamine D1 and D2 receptors are differentially regulated following buprenorphine or methadone treatment.Commentary on Rosenthal et al. (2013): Buprenorphine implant-new hopes, old questions.Novel treatment options in depression and psychosis.Buprenorphine treatment formulations: Preferences among persons in opioid withdrawal management
P2860
Q24185775-B5B4353E-3387-464A-BAE0-31C3758A3E87Q28082657-742686A7-C5C6-421F-A72C-34FE27668F15Q37705253-96AFF6D4-5461-4FC2-A9C6-E47B5D22EA93Q38244651-DA4AF6BE-5CF7-4BEE-9907-361586F52678Q38750450-B3703B90-BF5E-4E0F-9B67-A3830661D9C3Q38950890-3A6DEF52-C7E2-4E27-BD1A-EA117D8390ADQ38979423-97C3171E-BAD7-402F-B85F-25C696A26284Q44339691-B917AF62-1E69-427A-823F-FE9DB4E58088Q44344766-5E132400-D3AE-4459-B273-74690EF4A432Q45946172-7CDFB696-53D2-4240-88E4-5E06F54EFF6EQ47133543-60805F0E-7900-4CD1-81E9-6CE154BE6684Q48470145-7AE28785-843A-4C60-A5A2-0E6803BD4EA1Q52303526-C84ABC8D-BD84-4E0B-A7D4-D88D747E4E39Q52646032-B19F1F98-B00C-4063-A9CD-9CEFFE173F00Q57130271-5B2EC0F1-EE91-40A3-AF5E-813C214ADA43
P2860
Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Buprenorphine implants for tre ...... ingual buprenorphine/naloxone.
@ast
Buprenorphine implants for tre ...... ingual buprenorphine/naloxone.
@en
type
label
Buprenorphine implants for tre ...... ingual buprenorphine/naloxone.
@ast
Buprenorphine implants for tre ...... ingual buprenorphine/naloxone.
@en
prefLabel
Buprenorphine implants for tre ...... ingual buprenorphine/naloxone.
@ast
Buprenorphine implants for tre ...... ingual buprenorphine/naloxone.
@en
P2093
P2860
P921
P356
P1433
P1476
Buprenorphine implants for tre ...... ingual buprenorphine/naloxone.
@en
P2093
Ashwin Patkar
Frank Vocci
Genie L Bailey
Katherine L Beebe
Kyle Kampman
Paul Casadonte
Richard N Rosenthal
Stacey Sigmon
Steven Chavoustie
Walter Ling
P2860
P304
P356
10.1111/ADD.12315
P407
P577
2013-09-18T00:00:00Z